Global Summit Reviews Advances and Opportunities for Strategic Collaborations to Speed Pathways to MS Cures
Pathways to Cures Global Summit I (Stuart Schlossman) was fortunate to have been asked, and to have attended this Global…
Pictures of the Physiological Changes of MS
How does MS wreak its damage? If you or a loved one has multiple sclerosis (MS), you already know about the…
Stuart Schlossman
MS facts vs. myths
Don’t let these common misconceptions keep you from getting the best treatments and having the greatest possible quality of…
Stuart Schlossman
TISCH MS Research Center News: Phase II results of our FDA-approved stem cell treatment study have been released
We are very excited to share that the highly-anticipated Phase II results of our FDA-approved stem cell treatment study…
Stuart Schlossman
Understanding MS Eye Twitch
Multiple sclerosis (MS) is an autoimmune disease that affects the central nervous system (CNS). The CNS includes the brain, spinal…
Stuart Schlossman
MS becomes a treatable disease: 30 years later
Fred D Lublin fred.lublin@mssm.edu and Stephen C KriegerView all authors and affiliations OnlineFirst https://doi.org/10.1177/135245852311747 Abstract 30 years ago the first disease-modifying therapy for relapsing multiple…
Stuart Schlossman
Living with multiple sclerosis: Telling your employer
Click to Subscribe for the MS Beacon eNewsletter, resources and MS education Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews…
Stuart Schlossman
Stu’s Views on Advising a child about MS
The information found below is an Opinion only, from Stuart Schlossman, an MS Patient My Name: Stuart Schlossman Age –…
Stuart Schlossman
What Happens if Multiple Sclerosis Goes Untreated?
Multiple sclerosis drugs have been proved to reduce relapses. But some with MS still say no to treatment. By Becky UphamMedically…
Stuart Schlossman
Mavenclad benefits for MS sustained up to 15 years after last treatment
More than half who received it in clinical trials didn’t need further DMTs by Steve Bryson, PhD | April 11, 2023 The benefits…
Stuart Schlossman
